Lipocine Historical PE Ratio image   This LPCN PE ratio history page last updated 3/21/2024
Lipocine Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/7/2024
3.63-0.42-1.68NA
Q3 2023
11/8/2023
2.49-1.27-5.08NA
Q2 2023
8/10/2023
5.01-0.68-2.72NA
Q1 2023
5/11/2023
4.85-0.68-2.72NA
Q4 2022
3/10/2023
5.24-0.51-2.04NA
Q3 2022
11/9/2022
6.26-0.51-2.04NA
Q2 2022
8/8/2022
12.44-0.68-2.72NA
Q1 2022
5/9/2022
13.46-0.68-2.72NA
Q4 2021
3/9/2022
25.502.389.522.7
Q3 2021
11/10/2021
19.89-0.51-2.04NA
Q2 2021
8/5/2021
22.44-0.51-2.04NA
Q1 2021
5/6/2021
23.12-0.68-2.72NA
Q4 2020
3/11/2021
28.39-1.02-4.08NA
Q3 2020
11/10/2020
23.80-1.19-4.76NA
Q2 2020
8/6/2020
32.56-2.21-8.84NA
Q1 2020
5/7/2020
11.39-2.38-9.52NA
Q4 2019
3/13/2020
6.21-1.70-6.80NA
Q3 2019
11/12/2019
13.45-2.04-8.16NA
Q2 2019
8/7/2019
32.30-2.38-9.52NA
Q1 2019
5/8/2019
31.45-2.38-9.52NA
Q4 2018
3/6/2019
33.66-2.55-10.20NA
Q3 2018
11/7/2018
25.33-2.04-8.16NA
Q2 2018
8/7/2018
23.97-2.55-10.20NA
Q1 2018
5/7/2018
26.69-2.21-8.84NA
Q4 2017
3/12/2018
25.16-4.25-17.00NA
Q3 2017
11/8/2017
60.18-3.74-14.96NA
Q2 2017
8/7/2017
76.33-5.27-21.08NA
Q1 2017
5/8/2017
67.66-4.42-17.68NA
Q4 2016
3/6/2017
65.96-2.72-10.88NA
Q3 2016
11/8/2016
56.61-3.06-12.24NA
Q2 2016
8/9/2016
73.44-5.44-21.76NA
Q1 2016
5/9/2016
150.79-6.46-25.84NA
Q4 2015
3/10/2016
160.99-4.25-17.00NA
Q3 2015
11/12/2015
173.74-5.95-23.80NA
Q2 2015
8/11/2015
295.29-4.42-17.68NA
Q1 2015
5/7/2015
115.43-3.91-15.64NA
Q4 2014
3/11/2015
116.79-5.44-21.76NA
Q3 2014
11/10/2014
70.04-5.44-21.76NA
Q2 2014
8/13/2014
150.42-9.35-37.40NA
Lipocine PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/7/2024
3.63-0.42-3.05NA
Q3 2023
11/8/2023
2.49-1.27-3.14NA
Q2 2023
8/10/2023
5.01-0.68-2.38NA
Q1 2023
5/11/2023
4.85-0.68-2.38NA
Q4 2022
3/10/2023
5.24-0.51-2.38NA
Q3 2022
11/9/2022
6.26-0.510.5112.3
Q2 2022
8/8/2022
12.44-0.680.5124.4
Q1 2022
5/9/2022
13.46-0.680.6819.8
Q4 2021
3/9/2022
25.502.380.6837.5
Q3 2021
11/10/2021
19.89-0.51-2.72NA
Q2 2021
8/5/2021
22.44-0.51-3.40NA
Q1 2021
5/6/2021
23.12-0.68-5.10NA
Q4 2020
3/11/2021
28.39-1.02-6.80NA
Q3 2020
11/10/2020
23.80-1.19-7.48NA
Q2 2020
8/6/2020
32.56-2.21-8.33NA
Q1 2020
5/7/2020
11.39-2.38-8.50NA
Q4 2019
3/13/2020
6.21-1.70-8.50NA
Q3 2019
11/12/2019
13.45-2.04-9.35NA
Q2 2019
8/7/2019
32.30-2.38-9.35NA
Q1 2019
5/8/2019
31.45-2.38-9.52NA
Q4 2018
3/6/2019
33.66-2.55-9.35NA
Q3 2018
11/7/2018
25.33-2.04-11.05NA
Q2 2018
8/7/2018
23.97-2.55-12.75NA
Q1 2018
5/7/2018
26.69-2.21-15.47NA
Q4 2017
3/12/2018
25.16-4.25-17.68NA
Q3 2017
11/8/2017
60.18-3.74-16.15NA
Q2 2017
8/7/2017
76.33-5.27-15.47NA
Q1 2017
5/8/2017
67.66-4.42-15.64NA
Q4 2016
3/6/2017
65.96-2.72-17.68NA
Q3 2016
11/8/2016
56.61-3.06-19.21NA
Q2 2016
8/9/2016
73.44-5.44-22.10NA
Q1 2016
5/9/2016
150.79-6.46-21.08NA
Q4 2015
3/10/2016
160.99-4.25-18.53NA
Q3 2015
11/12/2015
173.74-5.95-19.72NA
Q2 2015
8/11/2015
295.29-4.42-19.21NA
Q1 2015
5/7/2015
115.43-3.91-24.14NA
Q4 2014
3/11/2015
116.79-5.44NANA
Q3 2014
11/10/2014
70.04-5.44NANA
Q2 2014
8/13/2014
150.42-9.35NANA
Quotes delayed 20 minutes

Email EnvelopeFree LPCN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Lipocine (LPCN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

LPTX PE Ratio History
LQDA PE Ratio History
LRMR PE Ratio History
LTRN PE Ratio History
LUCD PE Ratio History
LUMO PE Ratio History
LUNG PE Ratio History
LXEO PE Ratio History
LXRX PE Ratio History
LYEL PE Ratio History
How should the LPCN historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Lipocine. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this LPCN Historical PE Ratio page.

What is the average historical PE for LPCN based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The LPCN historical PE ratio using the annualized quarterly earnings method works out to 2.7.

What is the average historical PE for LPCN based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The LPCN historical PE ratio using the TTM earnings method works out to 23.5.

On this page we presented the Lipocine Historical PE Ratio information for Lipocine' stock. The average LPCN historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 2.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average LPCN historical PE based on this TTM earnings result method is 23.5. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this LPCN historical PE result, against the recent PE: when this page was posted on 3/20/2024, the most recent closing price for LPCN had been 4.23, and the most recent quarterly earnings result, annualized, was 9.52. Meanwhile, the most recent TTM earnings summed to 0.51. From these numbers, we calculate the recent LPCN PE on 3/20/2024 based on annualized quarterly EPS was 0.4. Based on LPCN's history, that recent PE is low relative to the historical average, with the recent PE 85.2% lower than the historical average PE across our data set for Lipocine. Looking at the recent LPCN PE on 3/20/2024 based on TTM EPS, we calculate the ratio at 8.3. Based on LPCN's history, that recent PE is low relative to the historical average, with the recent PE 64.7% lower than the average PE across our Lipocine data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on LPCN or any other given stock, valuation analysis for LPCN can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Lipocine PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for LPCN. Thanks for visiting, and the next time you need to research LPCN Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: GTYH Insider Buying, Top Ten Hedge Funds Holding BBEM, BSM market cap history.

 

Lipocine Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.